University of Bristol: Delaying Treatment For Localised Prostate Cancer Does Not Increase Mortality Risk, Trial Shows
March 13, 2023
March 13, 2023
BRISTOL, England, March 13 (TNSjou) -- The University of Bristol issued the following news release on March 12, 2023:
* * *
Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today. The latest findings from the ProtecT trial, led by the Universities of Oxford and Bristol, are presented today at the European Association of Urology (EAU) Congress in Milan and published in t . . .
* * *
Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today. The latest findings from the ProtecT trial, led by the Universities of Oxford and Bristol, are presented today at the European Association of Urology (EAU) Congress in Milan and published in t . . .